Cite

HARVARD Citation

    Abadia, B. et al. (2017). Success of Intravitreal Ranibizumab for Myopic Choroidal Neovascularization After 2 Years of Treatment. Journal of vitreoretinal diseases. pp. 122-125. [Online]. 
  
Back to record